Baidu Health and Organon Announce Strategic Collaboration at CIIE to Pioneer a New Ecosystem for Disease Education

On November 6, 2022, at the Fifth China International Import Expo (hereinafter referred to as the “CIIE”), Baidu Health and Organon, a global leader in healthcare, entered into a strategic partnership and held an official signing ceremony at their exhibition booth. The two parties will fully integrate their respective strengths, leveraging Organon’s leadership in medical science and Baidu Health’s technological advantages to explore digitalized and precision-oriented disease health education models for common chronic conditions. While creating high-quality, authoritative health science content, they will establish dedicated health education zones to connect users’ health needs with high-quality educational content and internet-based health services, thereby empowering the public’s ability to manage their own health and contributing to the improvement of citizens’ health literacy. Witnessing the on-site signing were He Mingke, Senior Vice President of Baidu Group; Li Xinyi, Head of Business Development at Baidu Health; Shi Ming, Vice President and Head of Commercial Excellence, Organon China; Lin Yuwei, Vice President and Head of Marketing for Legacy Brands, Organon China; and Yu Liheng, Deputy Director of Brand Marketing for Pain and Dermatology Categories, Organon China.

On-Site Signing Ceremony of the Strategic Cooperation Agreement Between Organon and Baidu Health

He Mingke, Senior Vice President of Baidu Group, stated, “In the post-pandemic era, the role of technology in the healthcare sector is becoming increasingly evident. Baidu aims to leverage its capabilities and strengths to empower the healthcare industry and make high-quality medical and health services universally accessible through technology. By partnering with Organon, Baidu Health seeks to jointly explore an ecosystem for disease education, better meeting users’ needs for online medical consultations and self-health management. This collaboration also aims to uncover greater possibilities for applying internet-based digital technologies in precise disease popularization, prevention, and control education, thereby contributing to the health of the entire population.”

Baidu Health is committed to building a health management platform that benefits the entire population, serving over 100 million healthcare users daily and fulfilling more than 200 million precise health-related searches per day. Every day, over 300,000 doctors from public hospitals provide 2.4 million online medical consultations to users through the Baidu Health platform.

Currently, Baidu Health has become one of the primary platforms for users to access health services, covering five major service scenarios: knowledge services, online consultation services, health e-commerce services, internet hospital services, and digital disease-specific alliances. It delivers a comprehensive range of services spanning science popularization and knowledge acquisition to long-term disease management, thereby building a diversified content and service ecosystem.

“The digital transformation of the healthcare industry and the rising health awareness among the public have imposed new requirements on disease education and disease management models,” said Shi Ming, Vice President and Head of Commercial Excellence at Organon China. “In China, Organon remains committed to addressing the health needs of women and their families, using this as a foundation to actively embrace digital innovation. We look forward to leveraging our strengths to foster ecosystem collaboration within the industry and empower stakeholders through digital solutions, enabling the public to access scientific, authoritative disease-related knowledge more clearly and rapidly, and helping more patients embrace healthier and better lives.”

Organon is dedicated to safeguarding women’s health across their entire life cycle, offering a global portfolio of more than 60 pharmaceutical and healthcare solutions that span a range of key therapeutic areas. In China, Organon focuses on two core business pillars—women’s health and its legacy brands—and is committed to being a pioneer in implementing innovative models for pharmaceutical retail in the country.